Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Publications

Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity.

Go S. et al, (2024), Elife, 13

HIFα isoform specific activities drive cell-type specificity ofVHL-associated oncogenesis

Lima JDCC. et al, (2024)

Microscale droplet assembly enables biocompatible multifunctional modular iontronics.

Zhang Y. et al, (2024), Science, 386, 1024 - 1030

Redefining PD1 as a guardian of stem-like T cells.

Jackson M. and Parkes EE., (2024), Nat Rev Immunol

The molecular reach of antibodies crucially underpins their viral neutralisation capacity

DUSHEK O., (2024), Nature Communications

Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study.

Hamilton F. et al, (2024), Lancet Microbe

Immunogenicity of MVA-BN vaccine deployed as mpox prophylaxis: a prospective cohort study and analysis of transcriptomic predictors of response

Drennan P. et al, (2024), The Lancet Microbe

Defining the genetic determinants of CD8+T cell receptor repertoire in the context of immune checkpoint blockade

Ng ES. et al, (2024)

A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.

Thomas T. et al, (2024), Nat Immunol, 25, 2152 - 2165

Validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries: a retrospective, comparative analysis.

Jackson A. et al, (2024), Lancet Oncol, 25, 1476 - 1486

Generation of T cells with reduced off-target cross-reactivities by engineering co-signalling receptors

Cabezas-Caballero J. et al, (2024)

Cytomegalovirus infection protects against metastatic melanoma and modulates oncological outcome and toxicity to checkpoint immunotherapy

Milotay G. et al, (2024)

Estimating Long-Term Survivorship Rates Among Patients With Resected Stage III/IV Melanoma: Analyses From CheckMate 238 and European Organization for Research and Treatment of Cancer 18071 Trials.

Weber JS. et al, (2024), J Clin Oncol

Novel H-2Db-restricted CD8 epitope derived from mouse MAGE-type antigen P1A mediates antitumor immunity in C57BL/6 mice.

McAuliffe J. et al, (2024), J Immunother Cancer, 12

Prospective cohort for early detection of liver cancer (Pearl): a study protocol.

Khanna K. et al, (2024), BMJ Open, 14

TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation.

Mühlgrabner V. et al, (2024), Sci Adv, 10

A retrospective analysis of the validity and timeliness of cancer diagnosis data collected during a prospective cohort study and reported by the English and Welsh cancer registries

Jackson A. et al, (2024), The Lancet Oncology

Immune Microenvironment Modulation following Neo-adjuvant Therapy for Oesophageal Adenocarcinoma: A Translational Analysis of the DEBIOC Clinical Trial

Scanlon E. et al, (2024), ESMO Open

Hif-2α programmes oxygen chemosensitivity in chromaffin cells.

Prange-Barczynska M. et al, (2024), J Clin Invest

Interferon-γ driven differentiation of monocytes into PD-L1+and MHC II+macrophages and the frequency of Tim-3+tumor-reactive CD8+T cells within the tumor microenvironment predict a positive response to anti-PD-1-based therapy in tumor-bearing mice

Gabrilo J. et al, (2024)

Load More